Clinical Trial Update: The Effects of Intravenous Heme Arginate on Heme Oxygenase-1 Expression (HO-1) and Oxidative Stress in the Human Heart [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravenous heme arginate on HO-1 expression and oxidative stress in the human heart for myocardial ischemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Ischemia

Drugs mentioned

• Heme Arginate (heme arginate)

Snippet

Sponsor: Martin Andreas, M.D. | Conditions: Myocardial Ischemia | Phase 2 | Status: COMPLETED | Results posted: 2021-02-15